1. Home
  2. AREN vs INZY Comparison

AREN vs INZY Comparison

Compare AREN & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • INZY
  • Stock Information
  • Founded
  • AREN 2016
  • INZY 2015
  • Country
  • AREN United States
  • INZY United States
  • Employees
  • AREN N/A
  • INZY N/A
  • Industry
  • AREN Medical/Dental Instruments
  • INZY Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREN Health Care
  • INZY Health Care
  • Exchange
  • AREN Nasdaq
  • INZY Nasdaq
  • Market Cap
  • AREN 236.9M
  • INZY 255.3M
  • IPO Year
  • AREN N/A
  • INZY 2020
  • Fundamental
  • Price
  • AREN $5.93
  • INZY $3.99
  • Analyst Decision
  • AREN
  • INZY Buy
  • Analyst Count
  • AREN 0
  • INZY 9
  • Target Price
  • AREN N/A
  • INZY $15.22
  • AVG Volume (30 Days)
  • AREN 285.7K
  • INZY 1.3M
  • Earning Date
  • AREN 08-18-2025
  • INZY 08-05-2025
  • Dividend Yield
  • AREN N/A
  • INZY N/A
  • EPS Growth
  • AREN N/A
  • INZY N/A
  • EPS
  • AREN 0.16
  • INZY N/A
  • Revenue
  • AREN $128,781,000.00
  • INZY N/A
  • Revenue This Year
  • AREN $275.98
  • INZY N/A
  • Revenue Next Year
  • AREN N/A
  • INZY N/A
  • P/E Ratio
  • AREN $25.35
  • INZY N/A
  • Revenue Growth
  • AREN N/A
  • INZY N/A
  • 52 Week Low
  • AREN $0.56
  • INZY $0.72
  • 52 Week High
  • AREN $10.05
  • INZY $6.24
  • Technical
  • Relative Strength Index (RSI)
  • AREN 51.48
  • INZY 83.59
  • Support Level
  • AREN $5.07
  • INZY $3.94
  • Resistance Level
  • AREN $6.18
  • INZY $3.97
  • Average True Range (ATR)
  • AREN 0.71
  • INZY 0.01
  • MACD
  • AREN -0.02
  • INZY -0.10
  • Stochastic Oscillator
  • AREN 55.56
  • INZY 100.00

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

Share on Social Networks: